News

Morning briefing: Supermarket Income launches £100m share issue; Tufton Assets lifts dividend target by 10% after 13% quarterly rise; BioPharma Credit lends $45m to Kestra Medical

Supermarket Income REIT (SUPR) has launched a £100m share issue to fund the purchase of three supermarkets in Manchester, Edinburgh and Halifax for £118m and a further pipeline of six assets for £98m. The fund raise will comprise of a placing to professional investors and an offer to private investors through Retail Book. Chief executive Rob Abraham said: “This fundraise will enable us to continue executing SUPR’s growth strategy, and is the latest step towards our ambition of doubling the size of our portfolio. The pipeline of assets will be earnings-enhancing and aligns with our portfolio strategy of acquiring well-located grocery assets with strong trading histories, let on resilient triple-net leases.”

Tufton Assets (SHIP), the £264m shipping fund, has reported its strongest quarterly performance in nearly five years with net asset value per share rising 13% from $1.395 to $1.576 in the three months to 30 June. It said the NAV uplift was driven by rising charger rates and higher vessel values with the dry bulk market buoyed by demand from Asia and the tanker market boosted by trade route reconfiguration following the closure of the Strait of Hormuz. Encouraged by the strong outlook, the fund has raised its target annual dividend by 10% from $0.0 per share to $0.11, meaning a third quarter dividend of $0.0275p will be paid. Dividends are forecast to be covered 1.9 times by earnings in the next 18 months.

BioPharma Credit (BPCR) has agreed to invest up to $45m in a new senior secured loan to Kestra Medical Technologies of the US. The Nasdaq-listed digital healthcare company makes wearable medical devices such as a vest that monitors a patient’s heart rhythms and can deliver a life-saving defibrillation shock if needed. The investment will be in three tranches alongside BioPharma Credit Investments V fund.

Stay a step ahead. Our daily newsletter brings you the latest on investment trusts and active ETFs. Subscribe here.

Gavin Lumsden
Written By Gavin Lumsden

Head of News

Leave a Reply

Your email address will not be published. Required fields are marked *